What is Tulavi Therapeutics worth?
$83.0Mlast known valuation
Tulavi Therapeutics last raised $1.0M in its Seed Round (Dec 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Tulavi Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2021 | Seed Round | $1.0M | ▮ | ▮ |
| Feb 2021 | Early Stage VC | $7.5M | ▮ | ▮ |
| May 2020 | Seed Round | $3.0M | ▮ | ▮ |
| Apr 2018 | Seed Round | $3.0M | ▮ | ▮ |
How Tulavi Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Tulavi Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Tulavi Therapeutics worth?
- Tulavi Therapeutics's last known valuation is $83.0M.
- How much has Tulavi Therapeutics raised?
- Tulavi Therapeutics has raised $34.0M in total funding across 4 recorded rounds.
- When did Tulavi Therapeutics last raise?
- Tulavi Therapeutics last raised in Dec 2021 (Seed Round), raising $1.0M.